Ozanimod
Ozanimod is a pharmaceutical drug with 39 clinical trials. Currently 8 active trials ongoing. Historical success rate of 65.4%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
6
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.7%
17 of 28 finished
39.3%
11 ended early
8
trials recruiting
39
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
Clinical Trials (39)
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
Ozanimod in Patients With Alzheimer's Disease
Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 39